Pfizer: US ruling maintains Lipitor patent term (San Francisco Chronicle)

Pfizer: US ruling maintains Lipitor patent term (San Francisco Chronicle)
The U.S. Patent & Trademark Office on Tuesday issued a notice allowing drugmaker Pfizer Inc. to correct a technical defect in one of the patents involving Pfizer’s cholesterol medicine Lipitor, the world’s top-selling drug. The decision will result in…